The device's internal pump was associated with a heightened risk of adverse outcomes, including stroke and death. 

Nine different companies are included in the recall. 

This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.

This new analysis helps paint a better picture of how COVID-19 has affected patient care in the United States.

Patients with chronic kidney disease face an especially high risk of developing new-onset heart failure after discharge. 

After 12 months, AFib detection was much higher in stroke patients treated with an insertable cardiac monitor than those who received usual care. 

The new meta-analysis included data from 32 studies. 

The Society for Cardiovascular Angiography and Interventions is the latest industry organization to show its support of the new legislation. 

PCI may be seen as a "reasonable alternative to CABG" for many elderly patients, the research team observed. 

Virtual care, remote patient monitoring and AI-based research are three specific topics the groups are expected to discuss.